JorgeLHerreraMD

PubMed

• Acquired Immune Deficiency Syndrome Cholangiopathy: Case Series of Three Patients and Literature Review.
  Yasir Ahmed, Mustafeez Ur Rahman, Zoia Ehsan Khattak, Jorge Herrera, Eduardo Calderon
  Journal of Medical Cases. 2022-09-01
• The Liver in Systemic Disease.
  Jorge L. Herrera
  Clinics in Liver Disease. 2019-05-01
• 9 citations
  Sarcoidosis and the Liver.
  Manoj Kumar, Jorge L. Herrera
  Clinics in Liver Disease. 2019-03-02

Journal Articles

• Lack of Patient Compliance in Real-World Practice Negatively Affects Sustained Viral Response Rates to Direct Acting Agent Therapy for Hepatitis C  
  Jorge Herrera, MD, Digestive Diseases and Sciences

Books/Book Chapters

• Practical Management of Liver Diseases 
  Chapter: Complications of cirrhosis 
  Herrera JLEditors: Z.M. Younossi.Cambridge University Press, New York2008
• GI/Liver Secrets 
  Chapter: Antiviral therapy for hepatitis C infection 
  Smith JR, Herrera JLEditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia2001
• GI/Liver Secrets 
  Chapter: Antiviral therapy for hepatitis B 
  Herrera JL, Smith JREditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia2001
• GI/Liver Secrets 
  Chapter: Liver Abscess 
  Herrera JLEditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia2001
• Secrets In Gastroenterology and Hepatology 
  Chapter: Liver Abscess 
  Herrera JLEditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia1995
• Secrets In Gastroenterology and Hepatology 
  Chapter: Chronic Diarrhea 
  Herrera JLEditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia1995
• Join now to see all

Abstracts/Posters

• Tolerability and Efficacy of Direct Acting Antiviral Therapy for Hepatitis C in Clinical Practice
  Sbahi H, Henrderson P, Herrera J, 78th Annual Scientific Meeting of the American College of Gastroenterology, San Diego, CA, 10/1/2013
• Tolerability and Efficacy of Direct Acting Antiviral Therapy for Hepatitis C in Clinical Practice
  Sbahi H, Henrderson P, Herrera J, Am J Gastroenterol, 1/1/2013
• A surprising etiology of dysphagia in a patient with known Eosinophilic Esophagitis
  Keller CB, Herrera J, Annual Meeting of the American College of Gastroenterology, San Antonio, TX, 10/1/2010
• Are Patients Who Undergo Treatment for Chronic Hepatitis C (HCV) Vaccinated for Hepatitis A and B?
  Landreneau SW, Voelkel JP, Herrera JL, Annual Meeting of the American College of Gastroenterology, San Antonio, TX, 10/1/2010
• African American and Caucasian American patients with hepatitis C infection choose not to undergo antiviral therapy for similar reasons
  Kakati B, Herrera J, Annual Meeting of the American College of Gastroenterology, San Antonio, TX, 10/1/2010
• African American and Caucasian American patients with hepatitis C infection choose not to undergo antiviral therapy for similar reasons
  Kakati B, Herrera J, Am J Gastroenterol, 1/1/2010
• Are Patients Who Undergo Treatment for Chronic Hepatitis C (HCV) Vaccinated for Hepatitis A and B?
  Landreneau SW, Voelkel JP, Herrera JL, Am J Gastroenterol, 1/1/2010
• A surprising etiology of dysphagia in a patient with known Eosinophilic Esophagitis
  Keller CB, Herrera J, Am J Gastroenterol, 1/1/2010
• Most patients with hepatitis C (HCV) infection choose not to undergo antiviral therapy
  Kakati B, Zhao J, Herrera J, Annual Meeting of the American College of Gastroenterology, San Diego, CA, 10/1/2009
• Is colonoscopy a valid time to screen for diabetes mellitus?
  Herman M, DiPalma J, Herrera J, Am J Gastroenterol, 1/1/2009
• Most patients with hepatitis C (HCV) infection choose not to undergo antiviral therapy
  Kakati B, Zhao J, Herrera J, Am J Gastroenterol, 1/1/2009
• An unusual case of right upper quadrant pain
  Keller CB, Herrera JL, 72nd Annual Scientific Meeting of the American College of Gastroenterology, Philadelphia, PA, 10/1/2007
• A randomized, multi-center comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation
  DiPalma JA, Cleveland M, McGowan J, Herrera JL, Digestive Disease Week, Washington, DC, 5/1/2007
• A randomized, multi-center, placebo-controlled trial of polyethylene glycol for chronic treatment of chronic constipation
  DiPalma JA, Cleveland M, McGowan J, Herrera JL, Digestive Disease Week, Washington, DC, 5/1/2007
• A randomized, multi-center, placebo-controlled trial of polyethylene glycol for chronic treatment of chronic constipation
  DiPalma JA, Cleveland M, McGowan J, Herrera JL, Gastroenterology, 1/1/2007
• The diagnostic yield of a comprehensive metabolic evaluation in patients diagnosed with hepatitis C infection
  Rutland TJ, Voelkel JP, Herrera J, 71st Annual Scientific Meeting of the American College of Gastroenterology, Las Vegas, NV, 10/1/2006
• The diagnostic yield of a comprehensive metabolic evaluation in patients diagnosed with hepatitis C infection
  Rutland TJ, Voelkel JP, Herrera J, Am J Gastroenterol, 1/1/2006
• Acetaminophen overdose in pregnancy: A case report and review of the literature
  Wilkes JM, Herrera JL, 67th Annual Scientific Meeting of the American College of Gastroenterology, Seattle, WA, 1/1/2002
• Acetaminophen overdose in pregnancy: A case report and review of the literature
  Wilkes JM, Herrera JL, Am J Gastroenterol, 1/1/2002
• Only patients with a very low viral load at week 12 may still become sustained responders to interferon/ribavirin combination therapy for chronic hepatitis C infection
  Van Leeuwen DJ, Yee LJ, Herrera JL, Langner RG, 5th Schering Hepatitis Investigator’s Network Meeting, Orlando, FL, 2/1/2001
• Efficacy of interferon alfacon-1 in nonresponders and relapsers to interferon and ribavirin
  Sjogren MH, Wu G, Herrine S, Raufman JP, Bacon B, Epstein M, Medoff J, Chen S, Waters B, Krawitt E, Herrera J, Gastroenterology, 1/1/2000
• Combination therapy with interferon and ribavirin for chronic hepatitis C patients resistant to alpha interferon
  Herrera JL, 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, IL, 11/1/1998
• Combination therapy with interferon and ribavirin for chronic hepatitis C patients resistant to alpha interferon
  Herrera JL, Hepatology, 1/1/1998
• Hepatitis C virus (HCV) genotypes: Distribution in a non-tertiary care setting and its relationship to the clinical and histologic characteristics of patients with ch...
  Umana E, Herrera JL, 62nd Annual Scientific Meeting of the American College of Gastroenterology, Chicago, IL, 11/1/1997
• Assessment of HCV RNA and HCV genotypes from 1510 chronic HCV patients treated in community clinical practice in the United States
  Mutchnick M, Tamburro C, Hassanein T, Tong M, Herrera JL, Conrad A, Russell J, Blatt L, 97th Annual Meeting of the American Gastroenterological Association and the American Association for the Study of Liver Diseases, Washington, DC, 5/1/1997
• Join now to see all

Lectures

• Side effects and management of current HCV therapy 
  Washington, DC - 4/1/2013
• Evaluation of Liver Lesions 
  Washington, DC - 4/1/2013
• Hepatocellular Carcinoma: Surgery, embolization or Drug Therapy – How to tailor treatment to the patient 
  Washington, DC - 4/1/2013
• Current Management of Hepatitis B Infection 
  Jackson, MS - 2/1/2013
• Update on hepatitis C management 
  Destin, FL - 1/1/2013
• Update on hepatitis B management 
  Destin, FL - 1/1/2013
• Practical management of hepatitis B infection 
  Las Vegas, NV - 1/1/2012
• Difficult Hepatitis B infection cases 
  Rochester, NY - 1/1/2012
• 2011 Cutting Edge Hepatology: Translating research into clinical practice 
  Birmingham, AL - 9/1/2011
• Fatty Liver disease 
  Birmingham, AL - 9/1/2011
• Complications of hepatitis B infection 
  Miami, FL - 9/1/2011
• Early intervention with TIPS for bleeding esophageal varices 
  Miami, FL - 3/1/2011
• Future directions for finding a cure in hepatitis B 
  Charlottesville, VA - 1/1/2011
• Who and When to Refer for Liver Transplantation 
  Williamsburg, VA - 1/1/2010
• Portal Hypertensive Bleeding 
  Williamsburg, VA - 1/1/2010
• Hepatitis B Infection: Why we care and How to Treat 
  San Diego, CA - 1/1/2009
• Chronic hepatitis B infection 
  Las Vegas, NV - 1/1/2006
• Growth Factors in the Treatment of Chronic Hepatitis C 
  Baltimore, MD - 10/1/2003
• Ascites: Pathophysiology and Management 
  Seattle, WA - 10/1/2002
• Viral Hepatitis: Practical Management – PEG Interferons: How to Use Them 
  Las Vegas, NV - 1/1/2001
• Ascites – Learning Luncheon 
  Las Vegas, NV - 1/1/2001
• Medical Care of the Cirrhotic 
  Las Vegas, NV - 1/1/2001
• Approach to Abnormal Liver Tests 
  Point Clear, AL
• Join now to see all